Overall, our data suggests that the survival model constructed using the ANGPT2, EMCN, GLDN, USHBP1 and ZNF532 genes shows good predictive value and demonstrates potential for clinical use to evaluate the prognosis of patients with HCC. This evidence concerns the gene ZNF532 and hepatocellular carcinoma.